Available clinical practice guidelines and position statements include:
This clinical guideline was produced by a multidisciplinary working group led by the Mater Research Institute, The University of Queensland, Brisbane, Australia, under the auspices of the Stillbirth and Neonatal Death Alliance (SANDA) of the Perinatal Society of Australia and New Zealand (PSANZ) in partnership with the Centre of Research Excellence in Stillbirth and the Stillbirth Foundation Australia.
Fetal growth restriction (FGR) is associated with stillbirth, neonatal death and perinatal morbidity and an increased risk of adverse health outcomes into adulthood. Improving the detection and care of pregnancies with FGR is an important strategy to reduce adverse outcome and is relevant to all maternity care providers.
The death of a baby is a highly distressing event for parents and families. This section of the guideline aims to improve the quality of bereavement care for parents who experience stillbirth or neonatal death.